Skip to main content

Day: April 8, 2020

VGP NV: Oproeping tot de Algemene en de Buitengewone Algemene Vergadering van Aandeelhouders

PersberichtAntwerpen (Berchem), 8 april 2020, 07h00 CET                                        De aandeelhouders worden hierbij uitgenodigd om deel te nemen aan de gewone en de buitengewone algemene vergadering van de Vennootschap die zal plaatsvinden op de zetel van de Vennootschap te Uitbreidingstraat 72, 2600 Antwerpen, België, op vrijdag 8 mei 2020 om 10.00 uur, met de hierna vermelde agenda en voorstellen tot besluit.Informatieve nota:De raad van bestuur volgt de evolutie van de Covid-19-pandemie en de sanitaire maatregelen die de Belgische autoriteiten in dit verband uitvaardigen op de voet en blijft de impact ervan op de organisatie van algemene vergaderingen evalueren.De raad van bestuur heeft voorlopig besloten de algemene vergaderingen niet uit te stellen. De Vennootschap zal echter passende maatregelen nemen om ervoor te zorgen...

Continue reading

Isracann Closes JV Cannabis Farm Production Agreement With 3-Year Offtake in Israel

VANCOUVER, British Columbia, April 08, 2020 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company” or “Isracann”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce that further to its news release on March 24, 2020, it has acquired a 50% interest in a joint venture called Cannation Ltd. for a phased partnership of two near-term farm operations located in the Hefer Valley region of Israel.Cannation has an offtake agreement with Focus Medical Herbs Ltd. (“Focus Medical”), a licensed medical cannabis producer in Israel, for a three-year definitive supply agreement with Cannation for approximately 2,600kg of medical cannabis per year, for a total of up to 7,800kg of...

Continue reading

Zomedica Pharmaceuticals Corp. Announces Pricing of $4.0 Million Public Offering

ANN ARBOR, Mich., April 07, 2020 (GLOBE NEWSWIRE) — Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the pricing of its previously announced public offering of 33,333,334 common shares and warrants to purchase up to 16,666,667 common shares. The securities are being sold in a fixed combination consisting of one common share and 0.5 of a warrant at a combined public offering price of $0.12 per share and accompanying warrant. Each whole warrant will be exercisable for one common share. The gross proceeds to Zomedica from this offering are expected to be approximately $4.0 million, before deducting placement agent fees and other estimated offering expenses, and excluding the exercise of any warrants. All of the common shares and warrants in the offering...

Continue reading

Mersana Therapeutics Raises $65 Million in Gross Proceeds Through its At-the-Market Facility

CAMBRIDGE, Mass., April 07, 2020 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it has raised gross proceeds of approximately $65 million through its At-the-Market (ATM) facility with participation based on interest received from Avoro Capital Advisors LLC, Bain Capital Life Sciences, Consonance Capital Investors and David Mott, Mersana’s Chairman of the Board. The Company sold approximately 8.9 million shares of the Company’s common stock at a purchase price of $5.59 and 2.0 million shares at the closing price of $7.74, in each case the market price at the time of sale. Cowen is acting as the sales agent for the ATM...

Continue reading

Laurentian Bank announces the election of its Directors

MONTREAL, April 07, 2020 (GLOBE NEWSWIRE) — Laurentian Bank of Canada (TSX: LB) announces that the candidates nominated as directors of Laurentian Bank of Canada (the “Bank”), as identified in the Management Proxy Circular dated February 7, 2020, have all been elected. The election took place earlier today, during the Bank’s Annual Meeting of Shareholders. The detailed results of the vote are set out below.The 10 candidates nominated by management were elected as directors of the Bank:Voting results on all matters voted on at the Annual Meeting of Shareholders of the Bank will be published shortly on https://lbcfg.ca/, and filed on SEDAR.About Laurentian Bank Financial GroupFounded in 1846, Laurentian Bank Financial Group is a diversified financial services provider whose mission is to help its customers improve their financial...

Continue reading

La Banque Laurentienne annonce l’élection de ses administrateurs

MONTRÉAL, 07 avr. 2020 (GLOBE NEWSWIRE) — La Banque Laurentienne du Canada (TSX : LB) annonce que les candidats à l’élection des administrateurs de la Banque Laurentienne du Canada (la « Banque ») identifiés dans la circulaire de sollicitation de procurations du 7 février 2020 ont tous été élus. L’élection s’est déroulée plus tôt aujourd’hui, lors de l’assemblée annuelle des porteurs d’actions ordinaires de la Banque. Les résultats détaillés du vote sont indiqués ci-dessous.Les 10 candidats proposés par la direction et dont le nom est indiqué ci-dessous ont tous été élus aux fonctions d’administrateurs de la Banque :Les résultats du vote sur toutes les questions soumises à l’assemblée annuelle des porteurs d’actions ordinaires de la Banque seront publiés prochainement sur le site https://blcgf.ca/ et...

Continue reading

Avid Technology Issues Business Update in Response to Global Impact of COVID-19

Expects to report record growth in new paid subscriptions in first quarter, resulting in improving subscription and maintenance revenueRevises first quarter guidance and withdraws full-year 2020 guidance given the impact of COVID-19 on the business environmentCompany believes it maintains sufficient near-term liquidity with approximately $81 million in cash and cash equivalents at March 31, 2020Company to report first quarter 2020 results on May 7, 2020BURLINGTON, Mass., April 07, 2020 (GLOBE NEWSWIRE) — Avid® (Nasdaq: AVID) today issued a business update in response to the coronavirus (COVID-19) pandemic.  The Company is still completing its review of its first quarter results, which it will report on May 7, 2020.  Based on a preliminary review of results for the quarter, the Company expects that its subscription business will...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.